Why Argus Upgraded Vertex Pharma To Buy Last Week
September 29, 2015 at 08:07 AM EDT
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are down 17 percent year-to-date, despite crossing the $140 mark twice ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.